Biotechnology
The Biotechnology industry has a total of 646 stocks, with a combined market cap of $793.27 billion and total revenue of $97.81 billion.
Market Cap
793.27B
Revenue
97.81B
Profits
-45.03B
PE Ratio
n/a
Profit Margin
-46.04%
Dividend Yield
0.06%
646 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 113.97B | -0.46% | 1,400,110 | 11.10B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 51.04B | -0.38% | 1,791,174 | 14.09B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.16B | 0.88% | 761,070 | 2.35B |
| 4 | ARGX | argenx SE | 35.71B | 1.01% | 242,984 | 2.64B |
| 5 | ONC | BeOne Medicines Ltd. | 30.48B | -0.49% | 121,637 | 4.18B |
| 6 | BNTX | BioNTech SE | 26.48B | -0.90% | 852,334 | 2.97B |
| 7 | RPRX | Royalty Pharma plc | 18.98B | 0.93% | 2,652,966 | 2.26B |
| 8 | SMMT | Summit Therapeutics Inc. | 14.65B | 0.87% | 3,410,947 | - |
| 9 | GMAB | Genmab A/S | 13.57B | 0.14% | 680,183 | 3.23B |
| 10 | INSM | Insmed Incorporated | 13.25B | -1.29% | 2,767,831 | 381.03M |
| 11 | INCY | Incyte Corporation | 13.02B | -0.27% | 1,692,731 | 4.41B |
| 12 | EXEL | Exelixis, Inc. | 11.55B | 0.36% | 2,139,541 | 2.30B |
| 13 | ASND | Ascendis Pharma A/S | 10.71B | 2.15% | 357,798 | 398.51M |
| 14 | BMRN | BioMarin Pharmaceutical Inc. | 10.60B | -1.50% | 2,498,547 | 2.95B |
| 15 | MRNA | Moderna, Inc. | 10.10B | -4.22% | 9,862,216 | 3.18B |
| 16 | BPMC | Blueprint Medicines Corporation | 8.27B | -0.16% | 4,441,500 | 562.12M |
| 17 | VRNA | Verona Pharma plc | 7.80B | 1.86% | 1,433,796 | 118.54M |
| 18 | ROIV | Roivant Sciences Ltd. | 7.61B | -0.09% | 5,918,227 | 29.05M |
| 19 | TECH | Bio-Techne Corporation | 7.57B | -3.09% | 2,205,578 | 1.21B |
| 20 | RVMD | Revolution Medicines, Inc. | 7.49B | -0.45% | 1,286,114 | - |
| 21 | CORT | Corcept Therapeutics Incorporated | 7.32B | -1.39% | 1,301,078 | 685.45M |
| 22 | BBIO | BridgeBio Pharma, Inc. | 7.28B | 0.84% | 2,260,849 | 127.42M |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 6.71B | -0.59% | 635,737 | 4.06B |
| 24 | HALO | Halozyme Therapeutics, Inc. | 6.60B | -0.56% | 1,947,212 | 1.08B |
| 25 | MDGL | Madrigal Pharmaceuticals, Inc. | 6.09B | -1.87% | 292,501 | 317.38M |
| 26 | TLX | Telix Pharmaceuticals Limited | 5.83B | -0.69% | 8,168 | 484.69M |
| 27 | LEGN | Legend Biotech Corporation | 5.80B | 3.69% | 2,243,968 | 728.30M |
| 28 | TGTX | TG Therapeutics, Inc. | 5.73B | 6.10% | 2,945,046 | 386.39M |
| 29 | IONS | Ionis Pharmaceuticals, Inc. | 5.61B | 0.37% | 834,824 | 717.25M |
| 30 | NUVL | Nuvalent, Inc. | 5.60B | 1.48% | 235,914 | - |
| 31 | AXSM | Axsome Therapeutics, Inc. | 5.46B | 2.33% | 684,558 | 432.16M |
| 32 | ADMA | ADMA Biologics, Inc. | 4.76B | -1.92% | 1,556,042 | 459.38M |
| 33 | PCVX | Vaxcyte, Inc. | 4.49B | 2.84% | 1,092,282 | - |
| 34 | AKRO | Akero Therapeutics, Inc. | 4.30B | 1.79% | 998,300 | - |
| 35 | RNA | Avidity Biosciences, Inc. | 4.29B | 4.00% | 1,135,707 | 8.93M |
| 36 | RYTM | Rhythm Pharmaceuticals, Inc. | 4.21B | 2.76% | 690,839 | 136.86M |
| 37 | PTCT | PTC Therapeutics, Inc. | 4.10B | 1.17% | 1,174,840 | 1.77B |
| 38 | ZLAB | Zai Lab Limited | 3.96B | 1.27% | 890,002 | 418.33M |
| 39 | MRUS | Merus N.V. | 3.88B | -2.73% | 1,745,125 | 54.73M |
| 40 | SRPT | Sarepta Therapeutics, Inc. | 3.85B | -0.83% | 2,864,152 | 2.23B |
| 41 | KRYS | Krystal Biotech, Inc. | 3.83B | 0.45% | 233,156 | 333.45M |
| 42 | CYTK | Cytokinetics, Incorporated | 3.83B | -1.02% | 1,019,762 | 19.22M |
| 43 | SLNO | Soleno Therapeutics, Inc. | 3.79B | -2.40% | 736,725 | - |
| 44 | ACLX | Arcellx, Inc. | 3.65B | 1.18% | 435,469 | 76.81M |
| 45 | ACAD | ACADIA Pharmaceuticals Inc. | 3.57B | -1.98% | 1,499,543 | 996.28M |
| 46 | SWTX | SpringWorks Therapeutics, Inc. | 3.53B | 0.19% | 3,995,881 | 219.67M |
| 47 | RARE | Ultragenyx Pharmaceutical Inc. | 3.48B | 0.82% | 1,414,500 | 590.69M |
| 48 | PTGX | Protagonist Therapeutics, Inc. | 3.34B | 4.44% | 947,337 | 207.80M |
| 49 | CRSP | CRISPR Therapeutics AG | 3.33B | 1.37% | 2,597,156 | 37.68M |
| 50 | SRRK | Scholar Rock Holding Corporation | 3.25B | 11.13% | 2,542,008 | - |
| 51 | KYMR | Kymera Therapeutics, Inc. | 3.10B | 7.68% | 1,323,420 | 58.89M |
| 52 | MLTX | MoonLake Immunotherapeutics | 3.10B | -4.35% | 1,381,437 | - |
| 53 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.09B | 0.28% | 929,861 | 534.65M |
| 54 | VKTX | Viking Therapeutics, Inc. | 3.04B | 0.15% | 2,791,776 | - |
| 55 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.02B | 0.50% | 544,606 | 760.00K |
| 56 | MTSR | Metsera, Inc. | 3.01B | 0.31% | 558,059 | - |
| 57 | IMVT | Immunovant, Inc. | 2.74B | 4.43% | 1,885,605 | - |
| 58 | IBRX | ImmunityBio, Inc. | 2.56B | -1.02% | 7,131,324 | 31.22M |
| 59 | APLS | Apellis Pharmaceuticals, Inc. | 2.40B | 3.19% | 2,514,344 | 775.84M |
| 60 | AAPG | Ascentage Pharma Group International | 2.40B | -1.13% | 1,632 | 134.35M |
| 61 | XENE | Xenon Pharmaceuticals Inc. | 2.36B | 0.76% | 656,363 | 7.50M |
| 62 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.27B | -1.67% | 1,394,231 | 545.21M |
| 63 | MIRM | Mirum Pharmaceuticals, Inc. | 2.21B | 0.09% | 393,259 | 379.25M |
| 64 | APGE | Apogee Therapeutics, Inc. | 2.20B | 3.15% | 1,115,087 | - |
| 65 | NAMS | NewAmsterdam Pharma Company N.V. | 2.19B | 0.62% | 1,089,689 | 47.14M |
| 66 | VCEL | Vericel Corporation | 2.18B | 0.60% | 406,053 | 238.54M |
| 67 | BLTE | Belite Bio, Inc | 2.09B | -1.59% | 20,404 | - |
| 68 | DNLI | Denali Therapeutics Inc. | 2.07B | -1.39% | 2,051,954 | - |
| 69 | CGON | CG Oncology, Inc. | 2.03B | 0.04% | 1,163,432 | 662.00K |
| 70 | HRMY | Harmony Biosciences Holdings, Inc. | 2.01B | -0.37% | 502,475 | 744.85M |
| 71 | LGND | Ligand Pharmaceuticals Incorporated | 2.01B | 0.37% | 81,774 | 181.49M |
| 72 | VERA | Vera Therapeutics, Inc. | 1.95B | -4.28% | 3,478,818 | - |
| 73 | AGIO | Agios Pharmaceuticals, Inc. | 1.94B | -1.32% | 399,289 | 37.04M |
| 74 | IMCR | Immunocore Holdings plc | 1.91B | 0.85% | 201,967 | 333.58M |
| 75 | RXRX | Recursion Pharmaceuticals, Inc. | 1.86B | -6.92% | 32,931,378 | 59.79M |
| 76 | GLPG | Galapagos NV | 1.86B | -2.34% | 132,012 | 311.49M |
| 77 | TARS | Tarsus Pharmaceuticals, Inc. | 1.85B | 3.35% | 811,365 | 233.67M |
| 78 | IDYA | IDEAYA Biosciences, Inc. | 1.85B | - | 719,167 | 7.00M |
| 79 | FOLD | Amicus Therapeutics, Inc. | 1.84B | -2.30% | 3,731,976 | 543.14M |
| 80 | IRON | Disc Medicine, Inc. | 1.66B | 1.80% | 412,414 | - |
| 81 | BEAM | Beam Therapeutics Inc. | 1.66B | -0.87% | 2,030,940 | 63.58M |
| 82 | BHVN | Biohaven Ltd. | 1.65B | -0.06% | 1,098,550 | - |
| 83 | ARQT | Arcutis Biotherapeutics, Inc. | 1.61B | 1.81% | 1,332,042 | 212.82M |
| 84 | DYN | Dyne Therapeutics, Inc. | 1.59B | 4.33% | 2,458,859 | - |
| 85 | CNTA | Centessa Pharmaceuticals plc | 1.58B | -5.35% | 3,561,655 | 15.00M |
| 86 | EWTX | Edgewise Therapeutics, Inc. | 1.56B | 2.28% | 699,668 | - |
| 87 | LQDA | Liquidia Corporation | 1.54B | 2.39% | 2,893,224 | 14.14M |
| 88 | ADPT | Adaptive Biotechnologies Corporation | 1.50B | -1.10% | 1,014,334 | 189.53M |
| 89 | MESO | Mesoblast Limited | 1.47B | 1.31% | 179,244 | 5.67M |
| 90 | JANX | Janux Therapeutics, Inc. | 1.47B | -1.47% | 330,200 | 9.34M |
| 91 | ETNB | 89bio, Inc. | 1.45B | -0.99% | 2,027,730 | - |
| 92 | OCUL | Ocular Therapeutix, Inc. | 1.35B | 0.95% | 1,923,233 | 59.65M |
| 93 | INVA | Innoviva, Inc. | 1.33B | 1.34% | 1,059,223 | 369.84M |
| 94 | SPRY | ARS Pharmaceuticals, Inc. | 1.32B | -2.75% | 1,237,105 | 97.12M |
| 95 | TVTX | Travere Therapeutics, Inc. | 1.31B | -3.29% | 1,097,449 | 273.53M |
| 96 | MNKD | MannKind Corporation | 1.31B | -1.15% | 1,125,978 | 297.60M |
| 97 | CLDX | Celldex Therapeutics, Inc. | 1.30B | -0.71% | 665,525 | 7.56M |
| 98 | GPCR | Structure Therapeutics Inc. | 1.24B | -2.41% | 528,198 | - |
| 99 | VRDN | Viridian Therapeutics, Inc. | 1.16B | 0.57% | 421,396 | 302.00K |
| 100 | NVAX | Novavax, Inc. | 1.13B | -2.24% | 5,596,859 | 1.25B |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 1.09B | 1.25% | 1,039,106 | 247.30M |
| 102 | OCS | Oculis Holding AG | 1.07B | 2.14% | 34,216 | 847.33K |
| 103 | ELVN | Enliven Therapeutics, Inc. | 1.05B | -4.13% | 579,628 | - |
| 104 | WVE | Wave Life Sciences Ltd. | 1.04B | 1.05% | 726,792 | 104.94M |
| 105 | MLYS | Mineralys Therapeutics, Inc. | 1.02B | 1.10% | 415,796 | - |
| 106 | RCUS | Arcus Biosciences, Inc. | 1.02B | 0.31% | 638,997 | 141.00M |
| 107 | CVAC | CureVac N.V. | 1.00B | 0.45% | 437,517 | 566.04M |
| 108 | SYRE | Spyre Therapeutics, Inc. | 1.00B | 0.61% | 357,659 | - |
| 109 | GERN | Geron Corporation | 993.59M | 1.30% | 10,155,793 | 116.29M |
| 110 | SNDX | Syndax Pharmaceuticals, Inc. | 960.29M | 1.82% | 1,112,886 | 43.72M |
| 111 | NRIX | Nurix Therapeutics, Inc. | 952.94M | 2.80% | 853,770 | 56.42M |
| 112 | MDXG | MiMedx Group, Inc. | 935.69M | -1.32% | 431,399 | 352.38M |
| 113 | QURE | uniQure N.V. | 909.37M | 11.03% | 1,803,363 | 20.20M |
| 114 | NAGE | Niagen Bioscience, Inc. | 908.56M | -1.83% | 545,739 | 107.93M |
| 115 | CRMD | CorMedix Inc. | 893.93M | 6.46% | 2,539,285 | 82.55M |
| 116 | PHVS | Pharvaris N.V. | 874.61M | -2.38% | 81,019 | - |
| 117 | ARDX | Ardelyx, Inc. | 870.89M | -1.36% | 3,137,090 | 361.71M |
| 118 | PRAX | Praxis Precision Medicines, Inc. | 860.79M | 2.15% | 895,672 | 8.12M |
| 119 | LENZ | LENZ Therapeutics, Inc. | 853.95M | 3.94% | 156,234 | - |
| 120 | ZYME | Zymeworks Inc. | 845.26M | -0.57% | 263,632 | 93.38M |
| 121 | NUVB | Nuvation Bio Inc. | 843.85M | 1.22% | 4,380,468 | 10.96M |
| 122 | AVBP | ArriVent BioPharma, Inc. | 802.97M | 3.30% | 529,702 | - |
| 123 | IMNM | Immunome, Inc. | 793.55M | 1.16% | 563,907 | 10.94M |
| 124 | PHAR | Pharming Group N.V. | 791.77M | -7.81% | 11,214 | 320.71M |
| 125 | NTLA | Intellia Therapeutics, Inc. | 785.16M | -1.17% | 4,333,182 | 45.57M |
| 126 | GHRS | GH Research PLC | 777.83M | 0.88% | 138,491 | - |
| 127 | REPL | Replimune Group, Inc. | 751.60M | 0.62% | 798,754 | - |
| 128 | GYRE | Gyre Therapeutics, Inc. | 722.53M | -7.11% | 274,516 | 100.64M |
| 129 | XERS | Xeris Biopharma Holdings, Inc. | 714.29M | 0.68% | 1,950,239 | 222.55M |
| 130 | SION | Sionna Therapeutics, Inc. | 712.53M | 2.28% | 296,570 | - |
| 131 | VIR | Vir Biotechnology, Inc. | 711.93M | -2.46% | 1,169,993 | 20.86M |
| 132 | ABCL | AbCellera Biologics Inc. | 707.41M | -2.07% | 4,117,268 | 23.11M |
| 133 | DAWN | Day One Biopharmaceuticals, Inc. | 703.96M | 0.22% | 754,554 | 161.92M |
| 134 | IMTX | Immatics N.V. | 702.56M | 0.78% | 303,189 | 155.80M |
| 135 | KALV | KalVista Pharmaceuticals, Inc. | 686.08M | 1.92% | 418,455 | - |
| 136 | TRVI | Trevi Therapeutics, Inc. | 685.76M | 2.43% | 3,045,216 | - |
| 137 | COGT | Cogent Biosciences, Inc. | 682.46M | 6.21% | 2,728,437 | - |
| 138 | AVXL | Anavex Life Sciences Corp. | 664.19M | 0.78% | 581,695 | - |
| 139 | ABUS | Arbutus Biopharma Corporation | 651.19M | -0.29% | 685,817 | 6.40M |
| 140 | ORIC | ORIC Pharmaceuticals, Inc. | 651.17M | 0.88% | 1,483,878 | - |
| 141 | XNCR | Xencor, Inc. | 649.08M | 0.22% | 561,910 | 127.23M |
| 142 | LIMN | Liminatus Pharma, Inc. | 639.96M | 93.55% | 4,341,261 | - |
| 143 | ANAB | AnaptysBio, Inc. | 621.10M | -0.61% | 1,178,816 | 111.87M |
| 144 | TSHA | Taysha Gene Therapies, Inc. | 618.23M | 3.23% | 3,569,309 | 7.22M |
| 145 | KROS | Keros Therapeutics, Inc. | 613.70M | 1.79% | 512,206 | 214.71M |
| 146 | RGLS | Regulus Therapeutics Inc. | 612.45M | 1.89% | 2,361,153 | - |
| 147 | CAPR | Capricor Therapeutics, Inc. | 602.43M | 6.81% | 2,770,772 | 17.36M |
| 148 | BCAX | Bicara Therapeutics Inc. | 601.53M | -1.16% | 1,224,591 | - |
| 149 | AUTL | Autolus Therapeutics plc | 601.48M | 8.13% | 3,135,959 | 9.01M |
| 150 | IOVA | Iovance Biotherapeutics, Inc. | 601.08M | -1.64% | 6,845,072 | 212.68M |
| 151 | DNTH | Dianthus Therapeutics, Inc. | 597.53M | 3.45% | 160,053 | 6.52M |
| 152 | STOK | Stoke Therapeutics, Inc. | 594.01M | -0.55% | 372,306 | 190.91M |
| 153 | BCYC | Bicycle Therapeutics plc | 588.66M | 0.35% | 199,074 | 25.72M |
| 154 | MAZE | Maze Therapeutics, Inc. | 584.25M | -3.82% | 71,231 | 167.50M |
| 155 | UPB | Upstream Bio, Inc. | 582.59M | -0.09% | 201,314 | 2.30M |
| 156 | MNMD | Mind Medicine (MindMed) Inc. | 581.00M | 0.52% | 956,682 | - |
| 157 | SANA | Sana Biotechnology, Inc. | 575.17M | 9.91% | 6,313,689 | - |
| 158 | KURA | Kura Oncology, Inc. | 568.80M | 1.86% | 853,702 | 67.99M |
| 159 | EYPT | EyePoint Pharmaceuticals, Inc. | 567.70M | 0.61% | 466,703 | 56.04M |
| 160 | RLAY | Relay Therapeutics, Inc. | 555.48M | 0.31% | 1,057,297 | 7.68M |
| 161 | MRVI | Maravai LifeSciences Holdings, Inc. | 552.61M | -1.81% | 2,045,856 | 241.86M |
| 162 | TYRA | Tyra Biosciences, Inc. | 540.82M | -0.88% | 626,223 | - |
| 163 | VALN | Valneva SE | 539.81M | 1.28% | 4,726 | 201.10M |
| 164 | TBPH | Theravance Biopharma, Inc. | 538.51M | -2.18% | 261,278 | 65.27M |
| 165 | CGEM | Cullinan Therapeutics, Inc. | 515.79M | -3.64% | 327,750 | - |
| 166 | VERV | Verve Therapeutics, Inc. | 510.79M | 8.32% | 6,957,100 | 59.61M |
| 167 | ABVX | ABIVAX Société Anonyme | 509.11M | 1.12% | 249,294 | 11.46M |
| 168 | ARVN | Arvinas, Inc. | 505.10M | -0.43% | 1,990,136 | 426.90M |
| 169 | SVRA | Savara Inc. | 501.44M | -4.42% | 981,199 | - |
| 170 | ATAI | Atai Life Sciences N.V. | 497.87M | 0.40% | 2,020,477 | 1.86M |
| 171 | TRML | Tourmaline Bio, Inc. | 485.26M | 0.85% | 442,058 | - |
| 172 | ZVRA | Zevra Therapeutics, Inc. | 482.82M | -1.34% | 499,201 | 40.59M |
| 173 | ATYR | aTyr Pharma, Inc. | 476.17M | 4.09% | 3,039,875 | 235.00K |
| 174 | SEPN | Septerna, Inc. | 468.75M | 5.52% | 1,003,108 | 977.00K |
| 175 | OPT | Opthea Limited | 466.57M | 1.49% | 3,025 | 208.86K |
| 176 | FTRE | Fortrea Holdings Inc. | 463.57M | -2.10% | 3,061,611 | 2.69B |
| 177 | IVA | Inventiva S.A. | 462.32M | 0.30% | 5,790 | 14.59M |
| 178 | PRTC | PureTech Health plc | 456.47M | 1.88% | 2,235 | 4.83M |
| 179 | ORKA | Oruka Therapeutics, Inc. | 456.40M | 4.11% | 139,952 | - |
| 180 | RAPP | Rapport Therapeutics, Inc. | 450.74M | -5.44% | 180,488 | - |
| 181 | AMLX | Amylyx Pharmaceuticals, Inc. | 450.16M | 2.64% | 712,939 | -1.27M |
| 182 | CELC | Celcuity Inc. | 446.07M | -1.67% | 155,749 | - |
| 183 | ERAS | Erasca, Inc. | 444.76M | 2.61% | 2,095,035 | - |
| 184 | ALT | Altimmune, Inc. | 442.84M | -0.55% | 2,309,139 | 20.00K |
| 185 | MGTX | MeiraGTx Holdings plc | 440.40M | 0.37% | 343,949 | 34.51M |
| 186 | SAGE | Sage Therapeutics, Inc. | 424.57M | 3.59% | 899,902 | 47.40M |
| 187 | DNA | Ginkgo Bioworks Holdings, Inc. | 423.19M | -4.37% | 690,693 | 237.42M |
| 188 | TECX | Tectonic Therapeutic, Inc. | 422.37M | -0.18% | 56,871 | - |
| 189 | RGNX | REGENXBIO Inc. | 419.34M | -17.06% | 2,653,981 | 156.72M |
| 190 | HUMA | Humacyte, Inc. | 406.41M | -0.38% | 4,158,980 | 517.00K |
| 191 | ZBIO | Zenas BioPharma, Inc. | 402.03M | 1.05% | 105,394 | 15.00M |
| 192 | MBX | MBX Biosciences, Inc. | 396.41M | -13.05% | 154,771 | - |
| 193 | PGEN | Precigen, Inc. | 392.59M | - | 1,222,279 | 4.20M |
| 194 | MREO | Mereo BioPharma Group plc | 391.14M | -3.53% | 1,012,726 | 1.00M |
| 195 | ITOS | iTeos Therapeutics, Inc. | 389.63M | -0.20% | 1,099,697 | 35.00M |
| 196 | BNTC | Benitec Biopharma Inc. | 388.36M | -1.45% | 46,505 | - |
| 197 | FULC | Fulcrum Therapeutics, Inc. | 383.79M | 1.14% | 336,903 | 80.00M |
| 198 | TNGX | Tango Therapeutics, Inc. | 380.46M | 7.34% | 2,943,528 | 40.99M |
| 199 | AURA | Aura Biosciences, Inc. | 378.23M | -0.65% | 166,413 | - |
| 200 | CTMX | CytomX Therapeutics, Inc. | 378.11M | -4.38% | 2,208,734 | 147.56M |
| 201 | RIGL | Rigel Pharmaceuticals, Inc. | 374.78M | 2.09% | 159,778 | 203.08M |
| 202 | RZLT | Rezolute, Inc. | 368.59M | 1.41% | 549,971 | - |
| 203 | VIGL | Vigil Neuroscience, Inc. | 367.77M | -0.25% | 1,238,142 | - |
| 204 | ABSI | Absci Corporation | 362.27M | -0.35% | 2,751,490 | 4.82M |
| 205 | ADCT | ADC Therapeutics SA | 341.17M | 2.99% | 637,351 | 75.82M |
| 206 | VSTM | Verastem, Inc. | 339.59M | 0.16% | 1,196,218 | 10.00M |
| 207 | SLDB | Solid Biosciences Inc. | 329.44M | 10.68% | 2,794,609 | - |
| 208 | NGNE | Neurogene Inc. | 326.89M | 5.77% | 335,616 | 925.00K |
| 209 | PHAT | Phathom Pharmaceuticals, Inc. | 326.65M | -0.21% | 632,992 | 81.86M |
| 210 | CMPX | Compass Therapeutics, Inc. | 326.35M | 8.76% | 759,719 | 850.00K |
| 211 | ARCT | Arcturus Therapeutics Holdings Inc. | 323.01M | -2.85% | 474,518 | 143.68M |
| 212 | ABEO | Abeona Therapeutics Inc. | 314.50M | 0.62% | 673,882 | - |
| 213 | CDTX | Cidara Therapeutics, Inc. | 311.21M | -0.23% | 226,347 | 302.00K |
| 214 | TERN | Terns Pharmaceuticals, Inc. | 309.18M | 0.85% | 607,171 | - |
| 215 | HRTX | Heron Therapeutics, Inc. | 305.13M | -1.96% | 787,510 | 148.52M |
| 216 | CRVS | Corvus Pharmaceuticals, Inc. | 301.52M | 4.27% | 471,130 | - |
| 217 | XOMA | XOMA Royalty Corporation | 299.17M | - | 18,311 | 42.91M |
| 218 | RCKT | Rocket Pharmaceuticals, Inc. | 298.43M | -5.14% | 4,984,668 | - |
| 219 | ATXS | Astria Therapeutics, Inc. | 294.59M | -1.14% | 282,610 | - |
| 220 | OLMA | Olema Pharmaceuticals, Inc. | 288.05M | -0.24% | 848,476 | - |
| 221 | GOSS | Gossamer Bio, Inc. | 286.40M | - | 718,899 | 124.59M |
| 222 | TRDA | Entrada Therapeutics, Inc. | 286.28M | 2.40% | 107,234 | 172.22M |
| 223 | GLUE | Monte Rosa Therapeutics, Inc. | 284.18M | 0.22% | 507,307 | 159.49M |
| 224 | ALLO | Allogene Therapeutics, Inc. | 282.16M | - | 1,651,701 | 22.00K |
| 225 | TNXP | Tonix Pharmaceuticals Holding Corp. | 281.34M | -1.39% | 675,458 | 10.04M |
| 226 | ANNX | Annexon, Inc. | 279.77M | 4.94% | 3,272,768 | - |
| 227 | OCGN | Ocugen, Inc. | 278.28M | 7.41% | 11,083,753 | 4.52M |
| 228 | CADL | Candel Therapeutics, Inc. | 278.07M | -0.89% | 1,089,915 | - |
| 229 | AVIR | Atea Pharmaceuticals, Inc. | 273.00M | -1.24% | 295,004 | - |
| 230 | PRTA | Prothena Corporation plc | 272.36M | 3.69% | 1,496,886 | 137.94M |
| 231 | HCWB | HCW Biologics Inc. | 269.16M | -3.09% | 43,485 | 1.45M |
| 232 | LXRX | Lexicon Pharmaceuticals, Inc. | 260.40M | 8.46% | 7,858,684 | 31.21M |
| 233 | PVLA | Palvella Therapeutics, Inc. | 259.70M | -0.84% | 48,196 | - |
| 234 | TVGN | Tevogen Bio Holdings Inc. | 259.29M | 8.46% | 1,176,094 | - |
| 235 | AARD | Aardvark Therapeutics, Inc. | 259.27M | 2.14% | 33,681 | - |
| 236 | INZY | Inozyme Pharma, Inc. | 259.01M | 0.25% | 1,179,218 | - |
| 237 | VNDA | Vanda Pharmaceuticals Inc. | 258.72M | -1.13% | 624,674 | 201.35M |
| 238 | IMMP | Immutep Limited | 257.25M | - | 108,825 | 3.02M |
| 239 | SLN | Silence Therapeutics plc | 255.52M | -1.64% | 100,189 | 27.70M |
| 240 | RNAC | Cartesian Therapeutics, Inc. | 242.41M | -1.83% | 82,564 | 34.17M |
| 241 | DRTS | Alpha Tau Medical Ltd. | 241.39M | -3.06% | 79,081 | - |
| 242 | CRDF | Cardiff Oncology, Inc. | 240.82M | - | 739,025 | 587.00K |
| 243 | THRD | Third Harmonic Bio, Inc. | 238.27M | 0.19% | 183,326 | - |
| 244 | URGN | UroGen Pharma Ltd. | 236.99M | 4.47% | 1,478,914 | 91.87M |
| 245 | MDWD | MediWound Ltd. | 234.20M | -0.92% | 47,556 | 19.21M |
| 246 | TENX | Tenax Therapeutics, Inc. | 233.39M | -4.10% | 10,824 | - |
| 247 | MNPR | Monopar Therapeutics Inc. | 232.47M | 6.81% | 49,462 | - |
| 248 | DBVT | DBV Technologies S.A. | 231.39M | 4.55% | 32,186 | 3.50M |
| 249 | YMAB | Y-mAbs Therapeutics, Inc. | 231.01M | 2.42% | 144,156 | 88.66M |
| 250 | PROK | ProKidney Corp. | 230.36M | -0.25% | 460,193 | 306.00K |
| 251 | FHTX | Foghorn Therapeutics Inc. | 229.65M | -1.90% | 88,896 | 23.50M |
| 252 | TVRD | Tvardi Therapeutics, Inc. | 229.34M | 1.68% | 33,631 | - |
| 253 | DSGN | Design Therapeutics, Inc. | 227.07M | -4.15% | 63,461 | - |
| 254 | JBIO | Jade Biosciences, Inc. | 223.07M | -4.02% | 143,861 | - |
| 255 | NBTX | Nanobiotix S.A. | 220.93M | 0.88% | 5,390 | -7.44M |
| 256 | GNFT | Genfit S.A. | 219.50M | - | 190 | 73.19M |
| 257 | FENC | Fennec Pharmaceuticals Inc. | 218.19M | 2.93% | 61,603 | 30.91M |
| 258 | SCPH | scPharmaceuticals Inc. | 216.98M | -0.24% | 631,765 | 41.98M |
| 259 | NVCT | Nuvectis Pharma, Inc. | 212.00M | 1.02% | 50,476 | - |
| 260 | CRGX | CARGO Therapeutics, Inc. | 210.51M | 0.33% | 512,899 | - |
| 261 | KOD | Kodiak Sciences Inc. | 206.31M | -1.01% | 277,544 | - |
| 262 | IPHA | Innate Pharma S.A. | 202.19M | 0.47% | 13,662 | 20.83M |
| 263 | TIL | Instil Bio, Inc. | 198.96M | -11.83% | 405,796 | - |
| 264 | DRUG | Bright Minds Biosciences Inc. | 196.16M | 0.94% | 15,805 | - |
| 265 | OMER | Omeros Corporation | 193.36M | -1.20% | 661,928 | - |
| 266 | PRQR | ProQR Therapeutics N.V. | 188.56M | -1.10% | 221,646 | 21.21M |
| 267 | CDXS | Codexis, Inc. | 187.23M | -3.00% | 754,378 | 49.82M |
| 268 | IMAB | I-Mab | 187.00M | 27.93% | 3,353,605 | 569.46K |
| 269 | INBX | Inhibrx Biosciences, Inc. | 186.59M | -0.42% | 54,393 | 200.00K |
| 270 | CYBN | Cybin Inc. | 185.54M | 2.80% | 484,608 | - |
| 271 | ENGN | enGene Holdings Inc. | 184.54M | -5.48% | 49,073 | - |
| 272 | ENGNW | enGene Holdings Inc. | 184.54M | - | 11 | - |
| 273 | VYGR | Voyager Therapeutics, Inc. | 182.61M | -0.60% | 516,610 | 66.96M |
| 274 | ALMS | Alumis Inc. | 182.26M | -1.76% | 742,007 | 17.39M |
| 275 | PBYI | Puma Biotechnology, Inc. | 181.18M | 2.53% | 373,215 | 232.71M |
| 276 | FDMT | 4D Molecular Therapeutics, Inc. | 181.13M | 2.09% | 179,701 | 23.00K |
| 277 | ACTU | Actuate Therapeutics, Inc. | 179.52M | 0.44% | 59,645 | - |
| 278 | ELDN | Eledon Pharmaceuticals, Inc. | 178.45M | -1.65% | 190,482 | - |
| 279 | DMAC | DiaMedica Therapeutics Inc. | 175.39M | -2.62% | 108,155 | - |
| 280 | PRME | Prime Medicine, Inc. | 173.84M | 3.03% | 3,276,790 | 3.85M |
| 281 | INMB | INmune Bio, Inc. | 170.60M | -3.67% | 495,653 | 50.00K |
| 282 | LYEL | Lyell Immunopharma, Inc. | 169.70M | -14.92% | 785,781 | 65.00K |
| 283 | ACIU | AC Immune SA | 169.69M | 2.69% | 70,416 | 32.01M |
| 284 | ACRS | Aclaris Therapeutics, Inc. | 168.92M | -3.11% | 637,235 | 17.78M |
| 285 | OABI | OmniAb, Inc. | 168.82M | -1.43% | 802,173 | 26.74M |
| 286 | SLS | SELLAS Life Sciences Group, Inc. | 162.64M | 1.87% | 1,940,830 | - |
| 287 | VTYX | Ventyx Biosciences, Inc. | 160.11M | 13.07% | 3,920,541 | - |
| 288 | CGEN | Compugen Ltd. | 159.91M | - | 262,668 | 27.59M |
| 289 | LRMR | Larimar Therapeutics, Inc. | 157.51M | 0.41% | 739,774 | - |
| 290 | TLSA | Tiziana Life Sciences Ltd | 157.16M | -1.40% | 157,799 | - |
| 291 | ACOG | Alpha Cognition Inc. | 154.91M | 0.94% | 65,312 | 2.93M |
| 292 | ENTA | Enanta Pharmaceuticals, Inc. | 154.13M | 1.41% | 99,322 | 64.46M |
| 293 | SGMT | Sagimet Biosciences Inc. | 153.89M | 17.16% | 6,086,417 | - |
| 294 | FATE | Fate Therapeutics, Inc. | 153.61M | -5.63% | 799,838 | 13.34M |
| 295 | EDIT | Editas Medicine, Inc. | 150.68M | -1.10% | 3,177,164 | 35.84M |
| 296 | LCTX | Lineage Cell Therapeutics, Inc. | 150.03M | -0.18% | 844,060 | 9.56M |
| 297 | ALDX | Aldeyra Therapeutics, Inc. | 146.74M | -0.81% | 537,062 | - |
| 298 | IKT | Inhibikase Therapeutics, Inc. | 145.71M | -1.01% | 111,263 | 1.00 |
| 299 | EPRX | Eupraxia Pharmaceuticals Inc. | 144.19M | -0.76% | 9,469 | - |
| 300 | SPRO | Spero Therapeutics, Inc. | 143.13M | -3.76% | 1,771,965 | 44.58M |
| 301 | NTHI | NeOnc Technologies Holdings, Inc. | 142.32M | 1.49% | 16,883 | 79.99K |
| 302 | BDTX | Black Diamond Therapeutics, Inc. | 141.59M | -1.97% | 1,300,481 | 70.00M |
| 303 | AGEN | Agenus Inc. | 141.47M | -8.35% | 1,342,622 | 99.52M |
| 304 | ALEC | Alector, Inc. | 140.99M | -9.03% | 347,146 | 88.34M |
| 305 | RAPT | RAPT Therapeutics, Inc. | 134.93M | - | 278,951 | - |
| 306 | MOLN | Molecular Partners AG | 132.65M | -3.84% | 1,273 | 2.53M |
| 307 | NMRA | Neumora Therapeutics, Inc. | 131.03M | 2.54% | 544,845 | - |
| 308 | NKTX | Nkarta, Inc. | 129.85M | -3.17% | 372,320 | - |
| 309 | SEER | Seer, Inc. | 128.28M | -0.46% | 222,184 | 15.31M |
| 310 | KYTX | Kyverna Therapeutics, Inc. | 127.06M | 3.16% | 650,092 | - |
| 311 | HURA | TuHURA Biosciences, Inc. | 126.24M | 2.48% | 99,945 | - |
| 312 | GLSI | Greenwich LifeSciences, Inc. | 126.06M | 0.96% | 47,636 | - |
| 313 | NKTR | Nektar Therapeutics | 125.58M | -9.58% | 3,819,424 | 87.25M |
| 314 | ACHV | Achieve Life Sciences, Inc. | 122.26M | -7.96% | 441,108 | - |
| 315 | PLX | Protalix BioTherapeutics, Inc. | 121.00M | -5.00% | 474,623 | 59.76M |
| 316 | THTX | Theratechnologies Inc. | 120.94M | -0.76% | 179,090 | 88.67M |
| 317 | ASMB | Assembly Biosciences, Inc. | 120.75M | 2.25% | 20,830 | 32.15M |
| 318 | TARA | Protara Therapeutics, Inc. | 120.38M | -3.11% | 173,245 | - |
| 319 | ELTX | Elicio Therapeutics, Inc. | 119.39M | -6.17% | 40,382 | - |
| 320 | KRRO | Korro Bio, Inc. | 117.19M | 5.05% | 202,008 | 4.82M |
| 321 | CUPR | Cuprina Holdings (Cayman) Limited | 116.90M | 9.00% | 36,581 | 35.41K |
| 322 | SGMO | Sangamo Therapeutics, Inc. | 116.90M | - | 3,036,269 | 63.76M |
| 323 | OBIO | Orchestra BioMed Holdings, Inc. | 116.85M | -6.44% | 248,191 | 2.89M |
| 324 | MIST | Milestone Pharmaceuticals Inc. | 115.49M | 5.45% | 795,129 | - |
| 325 | EXOZ | eXoZymes, Inc. | 114.47M | 0.59% | 4,319 | -700.00 |
| 326 | ATOS | Atossa Therapeutics, Inc. | 111.06M | 0.32% | 682,293 | - |
| 327 | IVVD | Invivyd, Inc. | 110.98M | -4.54% | 1,073,727 | 36.69M |
| 328 | CABA | Cabaletta Bio, Inc. | 110.62M | -1.36% | 1,568,881 | - |
| 329 | LXEO | Lexeo Therapeutics, Inc. | 108.52M | 5.48% | 705,863 | - |
| 330 | CLLS | Cellectis S.A. | 108.44M | 0.70% | 110,621 | 54.75M |
| 331 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 107.68M | 3.90% | 169,846 | - |
| 332 | CTNM | Contineum Therapeutics, Inc. | 107.37M | -4.31% | 49,999 | - |
| 333 | ZNTL | Zentalis Pharmaceuticals, Inc. | 105.77M | -2.00% | 1,045,303 | 26.87M |
| 334 | CCCC | C4 Therapeutics, Inc. | 104.38M | -4.55% | 768,457 | 39.78M |
| 335 | SAVA | Cassava Sciences, Inc. | 102.41M | -1.40% | 557,763 | - |
| 336 | CRBU | Caribou Biosciences, Inc. | 101.38M | -3.54% | 446,400 | 9.92M |
| 337 | PLRX | Pliant Therapeutics, Inc. | 99.14M | -2.71% | 947,656 | - |
| 338 | IOBT | IO Biotech, Inc. | 98.82M | 3.45% | 132,750 | - |
| 339 | HLVX | HilleVax, Inc. | 97.23M | -1.52% | 101,202 | - |
| 340 | COYA | Coya Therapeutics, Inc. | 96.50M | 1.05% | 23,818 | 3.69M |
| 341 | TCRX | TScan Therapeutics, Inc. | 95.07M | -5.62% | 211,705 | 4.42M |
| 342 | GUTS | Fractyl Health, Inc. | 95.01M | -1.52% | 133,380 | 60.00K |
| 343 | GNLX | Genelux Corporation | 94.37M | 3.27% | 192,724 | 8.00K |
| 344 | NAUT | Nautilus Biotechnology, Inc. | 93.60M | -4.25% | 144,891 | - |
| 345 | CHRS | Coherus BioSciences, Inc. | 93.41M | 1.09% | 1,176,472 | 272.25M |
| 346 | SNTI | Senti Biosciences, Inc. | 92.85M | 5.01% | 23,917 | - |
| 347 | UNCY | Unicycive Therapeutics, Inc. | 92.79M | -0.75% | 3,556,858 | - |
| 348 | BMEA | Biomea Fusion, Inc. | 92.05M | -14.34% | 4,103,041 | - |
| 349 | MGNX | MacroGenics, Inc. | 91.48M | -3.33% | 257,661 | 154.05M |
| 350 | ANIX | Anixa Biosciences, Inc. | 91.48M | 1.79% | 34,911 | - |
| 351 | ENTX | Entera Bio Ltd. | 91.36M | -3.17% | 19,897 | 223.00K |
| 352 | VXRT | Vaxart, Inc. | 90.26M | -2.10% | 1,254,634 | 47.40M |
| 353 | CSBR | Champions Oncology, Inc. | 88.48M | 1.18% | 10,122 | 58.59M |
| 354 | VERU | Veru Inc. | 88.39M | -7.66% | 1,738,929 | 16.89M |
| 355 | TNYA | Tenaya Therapeutics, Inc. | 87.84M | 2.53% | 4,086,601 | - |
| 356 | ORMP | Oramed Pharmaceuticals Inc. | 87.83M | -5.70% | 356,598 | 2.00M |
| 357 | XBIT | XBiotech Inc. | 87.19M | -1.70% | 78,031 | - |
| 358 | JSPR | Jasper Therapeutics, Inc. | 85.63M | -5.00% | 214,340 | - |
| 359 | CLYM | Climb Bio, Inc. | 83.79M | -3.10% | 71,754 | - |
| 360 | ADAG | Adagene Inc. | 82.91M | -7.37% | 125,989 | 103.20K |
| 361 | GALT | Galectin Therapeutics Inc. | 82.28M | 0.78% | 185,892 | - |
| 362 | NTRB | Nutriband Inc. | 80.74M | -11.25% | 56,383 | 2.40M |
| 363 | OTLK | Outlook Therapeutics, Inc. | 80.14M | -2.09% | 859,869 | - |
| 364 | WHWK | Whitehawk Therapeutics, Inc. | 79.14M | -1.48% | 99,672 | 27.78M |
| 365 | INO | Inovio Pharmaceuticals, Inc. | 77.75M | -2.30% | 687,145 | 283.10K |
| 366 | GNTA | Genenta Science S.p.A. | 76.82M | -3.67% | 41,188 | - |
| 367 | PYXS | Pyxis Oncology, Inc. | 76.82M | -3.13% | 458,629 | 16.15M |
| 368 | EPIX | ESSA Pharma Inc. | 75.90M | 0.58% | 54,799 | - |
| 369 | ADAP | Adaptimmune Therapeutics plc | 75.78M | 0.25% | 398,986 | 179.64M |
| 370 | IGMS | IGM Biosciences, Inc. | 74.54M | -1.59% | 150,858 | 2.68M |
| 371 | IMUX | Immunic, Inc. | 74.06M | -0.27% | 14,785,454 | - |
| 372 | IMRX | Immuneering Corporation | 73.77M | 4.59% | 379,086 | - |
| 373 | SRZN | Surrozen, Inc. | 73.39M | 3.97% | 4,611 | 11.64M |
| 374 | ATHE | Alterity Therapeutics Limited | 71.46M | 1.29% | 16,959 | 2.30M |
| 375 | PDSB | PDS Biotechnology Corporation | 71.31M | -5.45% | 396,629 | - |
| 376 | ZURA | Zura Bio Limited | 71.16M | -2.54% | 674,163 | - |
| 377 | ARMP | Armata Pharmaceuticals, Inc. | 70.94M | -0.76% | 26,313 | 4.70M |
| 378 | STRO | Sutro Biopharma, Inc. | 69.62M | -9.36% | 1,418,477 | 66.43M |
| 379 | VTGN | Vistagen Therapeutics, Inc. | 68.40M | -0.84% | 54,291 | 698.00K |
| 380 | FBRX | Forte Biosciences, Inc. | 68.34M | 4.06% | 27,552 | - |
| 381 | MNOV | MediciNova, Inc. | 68.18M | -1.40% | 12,559 | - |
| 382 | BYSI | BeyondSpring Inc. | 67.73M | -0.59% | 4,357 | 1.88M |
| 383 | VANI | Vivani Medical, Inc. | 67.54M | 1.79% | 147,229 | - |
| 384 | SKYE | Skye Bioscience, Inc. | 66.62M | -4.02% | 238,154 | - |
| 385 | CRVO | CervoMed Inc. | 65.62M | 0.80% | 98,719 | 9.31M |
| 386 | ABOS | Acumen Pharmaceuticals, Inc. | 64.51M | -0.47% | 174,437 | - |
| 387 | ANRO | Alto Neuroscience, Inc. | 64.43M | -2.86% | 247,244 | - |
| 388 | ANL | Adlai Nortye Ltd. | 64.02M | 2.06% | 5,396 | 1.94M |
| 389 | RPTX | Repare Therapeutics Inc. | 63.91M | 2.76% | 146,187 | 1.07M |
| 390 | OKYO | OKYO Pharma Limited | 63.46M | -0.53% | 23,411 | - |
| 391 | MCRB | Seres Therapeutics, Inc. | 63.40M | 1.82% | 63,375 | - |
| 392 | IKNA | Ikena Oncology, Inc. | 62.74M | -2.99% | 30,100 | - |
| 393 | XCUR | Exicure, Inc. | 62.55M | -2.46% | 5,458 | 500.00K |
| 394 | MGX | Metagenomi, Inc. | 62.05M | -2.35% | 286,930 | 45.26M |
| 395 | ACET | Adicet Bio, Inc. | 61.99M | -5.25% | 361,484 | - |
| 396 | IMMX | Immix Biopharma, Inc. | 61.05M | 6.31% | 294,908 | - |
| 397 | KLRS | Kalaris Therapeutics, Inc. | 60.78M | 5.18% | 18,307 | - |
| 398 | ICCC | ImmuCell Corporation | 60.37M | -1.04% | 15,762 | 27.30M |
| 399 | CLSD | Clearside Biomedical, Inc. | 60.22M | 1.97% | 96,033 | 3.76M |
| 400 | TELO | Telomir Pharmaceuticals, Inc. | 59.82M | -4.74% | 1,560,535 | - |
| 401 | IRD | Opus Genetics, Inc. | 59.66M | 1.01% | 779,395 | 13.65M |
| 402 | ANVS | Annovis Bio, Inc. | 59.43M | -5.86% | 961,395 | - |
| 403 | SER | Serina Therapeutics, Inc. | 59.31M | 0.51% | 2,343 | 51.00K |
| 404 | MAIA | MAIA Biotechnology, Inc. | 59.10M | 10.80% | 2,350,592 | - |
| 405 | IFRX | InflaRx N.V. | 57.52M | -0.12% | 331,644 | 140.24K |
| 406 | DTIL | Precision BioSciences, Inc. | 56.88M | 0.59% | 50,126 | 51.14M |
| 407 | GANX | Gain Therapeutics, Inc. | 55.72M | -5.28% | 265,875 | - |
| 408 | FBIO | Fortress Biotech, Inc. | 55.59M | 1.62% | 198,744 | 57.78M |
| 409 | PRLD | Prelude Therapeutics Incorporated | 55.23M | -2.17% | 82,339 | 7.00M |
| 410 | HOWL | Werewolf Therapeutics, Inc. | 55.19M | -6.11% | 632,070 | 1.14M |
| 411 | QNCX | Quince Therapeutics, Inc. | 54.11M | 9.17% | 622,243 | - |
| 412 | VRCA | Verrica Pharmaceuticals Inc. | 53.97M | -1.92% | 266,549 | 7.18M |
| 413 | RENB | Renovaro Inc. | 53.84M | 5.60% | 3,814,030 | - |
| 414 | CBUS | Cibus, Inc. | 53.30M | -34.32% | 4,550,951 | 4.75M |
| 415 | KRON | Kronos Bio, Inc. | 53.04M | 28.91% | 12,023,351 | 9.19M |
| 416 | ATNM | Actinium Pharmaceuticals, Inc. | 52.72M | -1.17% | 191,740 | 81.00K |
| 417 | VTVT | vTv Therapeutics Inc. | 51.62M | 1.00% | 740 | 17.00K |
| 418 | APLT | Applied Therapeutics, Inc. | 51.51M | -3.09% | 884,185 | 265.00K |
| 419 | RNXT | RenovoRx, Inc. | 51.20M | 0.72% | 200,069 | 240.00K |
| 420 | NRXP | NRx Pharmaceuticals, Inc. | 50.83M | -0.34% | 295,329 | - |
| 421 | STTK | Shattuck Labs, Inc. | 50.78M | -8.62% | 80,594 | 4.61M |
| 422 | ADVM | Adverum Biotechnologies, Inc. | 50.56M | -2.02% | 91,298 | 1.00M |
| 423 | ATRA | Atara Biotherapeutics, Inc. | 50.19M | 1.08% | 38,620 | 199.73M |
| 424 | CNTX | Context Therapeutics Inc. | 49.48M | -4.12% | 291,195 | - |
| 425 | PMVP | PMV Pharmaceuticals, Inc. | 49.36M | 2.15% | 222,701 | - |
| 426 | IPSC | Century Therapeutics, Inc. | 48.51M | -0.71% | 750,146 | 114.90M |
| 427 | ARTV | Artiva Biotherapeutics, Inc. | 47.75M | -0.51% | 84,049 | 251.00K |
| 428 | CUE | Cue Biopharma, Inc. | 47.48M | 1.63% | 181,285 | 7.99M |
| 429 | AVTX | Avalo Therapeutics, Inc. | 46.88M | -0.46% | 495,868 | 441.00K |
| 430 | PEPG | PepGen Inc. | 46.46M | -5.96% | 75,548 | - |
| 431 | ANEB | Anebulo Pharmaceuticals, Inc. | 46.30M | 7.33% | 5,655 | - |
| 432 | CELU | Celularity Inc. | 45.98M | -6.80% | 203,471 | 54.22M |
| 433 | MRSN | Mersana Therapeutics, Inc. | 45.90M | -0.19% | 1,254,814 | 34.01M |
| 434 | OSTX | OS Therapies Incorporated | 45.80M | -1.81% | 122,003 | - |
| 435 | MURA | Mural Oncology plc | 44.73M | - | 126,460 | - |
| 436 | RNTX | Rein Therapeutics Inc. | 43.53M | -1.75% | 22,511 | - |
| 437 | CNTB | Connect Biopharma Holdings Limited | 43.34M | 1.13% | 26,149 | 26.03M |
| 438 | NRSN | NeuroSense Therapeutics Ltd. | 41.26M | 1.18% | 98,807 | - |
| 439 | AKTX | Akari Therapeutics, Plc | 41.25M | -5.03% | 16,751 | - |
| 440 | GRCE | Grace Therapeutics, Inc. | 40.19M | 1.74% | 13,508 | - |
| 441 | BRNS | Barinthus Biotherapeutics plc | 39.94M | -1.98% | 6,973 | 14.97M |
| 442 | RADX | Radiopharm Theranostics Limited | 39.59M | -7.20% | 6,848 | 204.61K |
| 443 | ACRV | Acrivon Therapeutics, Inc. | 39.19M | 1.63% | 539,490 | - |
| 444 | OKUR | OnKure Therapeutics, Inc. | 38.64M | -1.04% | 40,639 | - |
| 445 | ESLA | Estrella Immunopharma, Inc. | 38.34M | 7.07% | 118,439 | - |
| 446 | ITRM | Iterum Therapeutics plc | 38.00M | -1.02% | 186,124 | - |
| 447 | CAMP | Camp4 Therapeutics Corporation | 37.49M | -2.11% | 46,309 | 1.51M |
| 448 | PLUR | Pluri Inc. | 37.43M | 5.25% | 10,622 | 1.03M |
| 449 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 37.39M | -1.78% | 511,375 | - |
| 450 | ALGS | Aligos Therapeutics, Inc. | 36.99M | -2.23% | 78,650 | 3.27M |
| 451 | LTRN | Lantern Pharma Inc. | 36.99M | 2.69% | 54,871 | - |
| 452 | KPTI | Karyopharm Therapeutics Inc. | 36.72M | -2.07% | 54,801 | 142.13M |
| 453 | XLO | Xilio Therapeutics, Inc. | 35.12M | 1.86% | 645,309 | 9.27M |
| 454 | LVTX | LAVA Therapeutics N.V. | 34.20M | 0.78% | 8,699 | 4.99M |
| 455 | ANTX | AN2 Therapeutics, Inc. | 33.80M | 2.75% | 131,127 | - |
| 456 | LYRA | Lyra Therapeutics, Inc. | 33.57M | 11.00% | 932,468 | 1.19M |
| 457 | FBLG | FibroBiologics, Inc. | 32.68M | 0.52% | 224,074 | - |
| 458 | PULM | Pulmatrix, Inc. | 32.51M | -1.98% | 14,141 | 1.92M |
| 459 | PYPD | PolyPid Ltd. | 32.20M | 6.04% | 126,046 | - |
| 460 | IPA | ImmunoPrecise Antibodies Ltd. | 32.13M | 22.38% | 4,900,991 | 16.58M |
| 461 | KZR | Kezar Life Sciences, Inc. | 32.00M | 2.82% | 31,348 | - |
| 462 | COEP | Coeptis Therapeutics Holdings, Inc. | 31.62M | -5.06% | 12,644 | 62.87K |
| 463 | FGEN | FibroGen, Inc. | 30.83M | - | 429,057 | 7.00M |
| 464 | IMNN | Imunon, Inc. | 30.58M | -17.65% | 3,692,737 | - |
| 465 | RANI | Rani Therapeutics Holdings, Inc. | 30.43M | -5.54% | 327,417 | 1.20M |
| 466 | DYAI | Dyadic International, Inc. | 30.09M | 3.09% | 13,035 | 3.55M |
| 467 | ONCY | Oncolytics Biotech Inc. | 29.28M | -2.09% | 654,000 | - |
| 468 | MLEC | Moolec Science SA | 29.25M | -3.57% | 615 | 7.83M |
| 469 | TPST | Tempest Therapeutics, Inc. | 29.24M | 15.07% | 212,269 | - |
| 470 | INKT | MiNK Therapeutics, Inc. | 29.06M | 2.65% | 1,673 | - |
| 471 | CASI | CASI Pharmaceuticals, Inc. | 28.97M | -3.10% | 1,425 | 31.37M |
| 472 | DARE | Daré Bioscience, Inc. | 28.85M | 5.16% | 83,081 | 25.91K |
| 473 | CVKD | Cadrenal Therapeutics, Inc. | 28.73M | -5.68% | 20,390 | - |
| 474 | ALXO | ALX Oncology Holdings Inc. | 28.06M | -1.70% | 202,456 | - |
| 475 | PASG | Passage Bio, Inc. | 27.97M | -6.83% | 251,715 | - |
| 476 | VOR | Vor Biopharma Inc. | 27.94M | -2.23% | 845,528 | - |
| 477 | JUNS | Jupiter Neurosciences, Inc. | 27.42M | 1.63% | 114,978 | - |
| 478 | RLMD | Relmada Therapeutics, Inc. | 27.22M | 11.13% | 1,210,172 | - |
| 479 | OSRH | OSR Holdings, Inc. | 26.99M | 2.94% | 80,486 | -148.95K |
| 480 | KALA | KALA BIO, Inc. | 26.91M | 1.21% | 37,438 | - |
| 481 | BCAB | BioAtla, Inc. | 26.68M | -3.71% | 503,796 | 11.00M |
| 482 | BOLD | Boundless Bio, Inc. | 25.74M | -2.54% | 63,293 | - |
| 483 | CMMB | Chemomab Therapeutics Ltd. | 25.30M | -1.93% | 78,610 | - |
| 484 | CRIS | Curis, Inc. | 25.00M | 1.27% | 34,914 | 11.20M |
| 485 | GBIO | Generation Bio Co. | 24.51M | -5.63% | 678,052 | 24.56M |
| 486 | ABVC | ABVC BioPharma, Inc. | 24.38M | -5.06% | 349,242 | 508.38K |
| 487 | IGC | IGC Pharma, Inc. | 24.02M | -1.37% | 172,487 | 1.24M |
| 488 | CLGN | CollPlant Biotechnologies Ltd. | 23.48M | -6.82% | 90,843 | 2.47M |
| 489 | CALC | CalciMedica, Inc. | 23.47M | -2.05% | 27,075 | - |
| 490 | GDTC | CytoMed Therapeutics Limited | 23.31M | -1.85% | 8,214 | 368.84K |
| 491 | NNVC | NanoViricides, Inc. | 23.31M | -5.10% | 100,459 | - |
| 492 | LSTA | Lisata Therapeutics, Inc. | 22.79M | -0.38% | 7,394 | 1.00M |
| 493 | NRXS | NeurAxis, Inc. | 22.76M | -3.35% | 134,317 | 2.93M |
| 494 | QTTB | Q32 Bio Inc. | 22.44M | -4.66% | 172,778 | - |
| 495 | OVID | Ovid Therapeutics Inc. | 22.28M | 1.20% | 876,302 | 548.00K |
| 496 | APUS | Apimeds Pharmaceuticals US, Inc. | 21.99M | 1.06% | 76,749 | - |
| 497 | ENLV | Enlivex Therapeutics Ltd. | 21.94M | -1.08% | 23,504 | - |
| 498 | XFOR | X4 Pharmaceuticals, Inc. | 21.42M | -8.42% | 133,967 | 31.36M |
| 499 | BCTX | BriaCell Therapeutics Corp. | 20.34M | 1.52% | 106,972 | - |
| 500 | BIVI | BioVie Inc. | 20.20M | - | 144,219 | - |
| 501 | ADVB | Advanced Biomed Inc. | 20.14M | -2.97% | 16,732 | - |
| 502 | SLGL | Sol-Gel Technologies Ltd. | 19.89M | -3.25% | 14,950 | 12.10M |
| 503 | HOOK | HOOKIPA Pharma Inc. | 19.39M | -5.06% | 94,295 | 9.35M |
| 504 | LEXX | Lexaria Bioscience Corp. | 19.29M | 3.04% | 37,058 | 525.92K |
| 505 | LSB | LakeShore Biopharma Co., Ltd | 19.06M | -4.86% | 47,598 | 79.42M |
| 506 | BLRX | BioLineRx Ltd. | 18.87M | 13.21% | 274,671 | 22.34M |
| 507 | CLRB | Cellectar Biosciences, Inc. | 18.81M | -11.61% | 40,008,065 | - |
| 508 | ELEV | Elevation Oncology, Inc. | 18.07M | 0.30% | 292,605 | - |
| 509 | CING | Cingulate Inc. | 18.02M | 0.12% | 60,510 | - |
| 510 | CGTX | Cognition Therapeutics, Inc. | 17.98M | -5.69% | 7,063,213 | - |
| 511 | LGVN | Longeveron Inc. | 17.71M | -0.84% | 69,367 | 2.23M |
| 512 | MRKR | Marker Therapeutics, Inc. | 17.20M | -1.32% | 66,622 | 5.70M |
| 513 | SABS | SAB Biotherapeutics, Inc. | 17.05M | -1.77% | 2,930 | 377.84K |
| 514 | COCP | Cocrystal Pharma, Inc. | 16.79M | -0.06% | 118,038 | - |
| 515 | LPCN | Lipocine Inc. | 16.70M | -2.44% | 14,775 | 3.67M |
| 516 | VYNE | VYNE Therapeutics Inc. | 16.66M | 1.01% | 85,109 | 605.00K |
| 517 | ASBP | Aspire Biopharma Holdings, Inc. | 16.63M | -12.82% | 1,700,679 | - |
| 518 | LPTX | Leap Therapeutics, Inc. | 16.38M | -2.40% | 216,739 | - |
| 519 | EVAX | Evaxion A/S | 16.30M | -7.19% | 81,028 | 3.29M |
| 520 | HOTH | Hoth Therapeutics, Inc. | 15.98M | -20.92% | 9,832,313 | - |
| 521 | PMN | ProMIS Neurosciences, Inc. | 15.72M | -4.56% | 62,485 | - |
| 522 | CANF | Can-Fite BioPharma Ltd. | 15.47M | -2.70% | 44,434 | 674.00K |
| 523 | IBIO | iBio, Inc. | 15.31M | -6.25% | 460,373 | 375.00K |
| 524 | GOVX | GeoVax Labs, Inc. | 15.09M | -2.68% | 413,667 | 5.59M |
| 525 | MEIP | MEI Pharma, Inc. | 14.33M | -1.83% | 6,790 | - |
| 526 | SYBX | Synlogic, Inc. | 14.27M | -0.81% | 2,965 | 8.00K |
| 527 | RLYB | Rallybio Corporation | 14.12M | -9.79% | 1,143,256 | 848.00K |
| 528 | NXTC | NextCure, Inc. | 13.90M | 4.73% | 440,155 | - |
| 529 | LIPO | Lipella Pharmaceuticals Inc. | 13.80M | 4.22% | 56,427 | 519.87K |
| 530 | PRTG | Portage Biotech Inc. | 13.79M | -3.46% | 26,819 | - |
| 531 | EDSA | Edesa Biotech, Inc. | 13.76M | 0.51% | 14,539 | - |
| 532 | MTVA | MetaVia Inc. | 13.50M | 0.47% | 184,198 | - |
| 533 | CYCC | Cyclacel Pharmaceuticals, Inc. | 13.47M | -58.28% | 5,640,315 | 14.00K |
| 534 | NEUP | Neuphoria Therapeutics Inc. | 13.44M | - | 16,149 | 15.66M |
| 535 | BRTX | BioRestorative Therapies, Inc. | 13.43M | 1.42% | 8,561 | 391.00K |
| 536 | ATHA | Athira Pharma, Inc. | 13.32M | 3.39% | 580,398 | - |
| 537 | EQ | Equillium, Inc. | 12.95M | -1.73% | 42,091 | 30.41M |
| 538 | ABP | Abpro Holdings, Inc. | 12.91M | 0.52% | 628,415 | 183.00K |
| 539 | PHGE | BiomX Inc. | 12.83M | -4.48% | 60,006 | - |
| 540 | GLYC | GlycoMimetics, Inc. | 12.82M | -5.43% | 27,506,650 | - |
| 541 | ICU | SeaStar Medical Holding Corporation | 12.59M | -1.49% | 91,185 | 428.00K |
| 542 | NERV | Minerva Neurosciences, Inc. | 12.52M | -3.24% | 19,070 | - |
| 543 | INAB | IN8bio, Inc. | 12.41M | -1.96% | 3,860,657 | - |
| 544 | CVM | CEL-SCI Corporation | 12.12M | -2.07% | 175,760 | - |
| 545 | ALLR | Allarity Therapeutics, Inc. | 12.05M | -8.11% | 663,635 | - |
| 546 | CLDI | Calidi Biotherapeutics, Inc. | 11.98M | -2.22% | 384,622 | - |
| 547 | UBX | Unity Biotechnology, Inc. | 11.84M | -4.76% | 112,791 | - |
| 548 | PHIO | Phio Pharmaceuticals Corp. | 11.75M | 17.14% | 6,880,672 | - |
| 549 | CSCI | COSCIENS Biopharma Inc. | 11.53M | 0.27% | 2,704 | 9.03M |
| 550 | BOLT | Bolt Biotherapeutics, Inc. | 11.43M | -7.97% | 247,391 | 3.64M |
| 551 | ERNA | Ernexa Therapeutics Inc. | 11.35M | 1.11% | 491,582 | 535.00K |
| 552 | BCDA | BioCardia, Inc. | 11.03M | -1.84% | 10,249 | 3.00K |
| 553 | IMRN | Immuron Limited | 10.18M | -3.41% | 16,493 | 4.05M |
| 554 | CYCN | Cyclerion Therapeutics, Inc. | 10.14M | 0.96% | 8,867 | 2.08M |
| 555 | XTLB | XTL Biopharmaceuticals Ltd. | 10.10M | -4.53% | 4,491 | 451.00K |
| 556 | APRE | Aprea Therapeutics, Inc. | 10.01M | -6.70% | 31,918 | 1.28M |
| 557 | MBRX | Moleculin Biotech, Inc. | 9.75M | 2.46% | 1,789,860 | - |
| 558 | KPRX | Kiora Pharmaceuticals, Inc. | 9.41M | -3.13% | 355,748 | 20.00K |
| 559 | DWTX | Dogwood Therapeutics, Inc. | 9.34M | -8.52% | 114,214 | - |
| 560 | BTAI | BioXcel Therapeutics, Inc. | 9.27M | - | 162,286 | 1.85M |
| 561 | SNSE | Sensei Biotherapeutics, Inc. | 9.10M | 2.53% | 134,039 | - |
| 562 | EYEN | Eyenovia, Inc. | 9.05M | 50.96% | 14,808,658 | 67.06K |
| 563 | BCLI | Brainstorm Cell Therapeutics Inc. | 8.94M | 0.89% | 199,848 | - |
| 564 | CTXR | Citius Pharmaceuticals, Inc. | 8.81M | -2.08% | 106,330 | - |
| 565 | KAPA | Kairos Pharma, Ltd. | 8.47M | -3.48% | 1,927,880 | - |
| 566 | INTS | Intensity Therapeutics, Inc. | 8.25M | -4.98% | 188,689 | - |
| 567 | AEON | AEON Biopharma, Inc. | 8.25M | 11.50% | 676,309 | - |
| 568 | TRAW | Traws Pharma, Inc. | 8.24M | -13.95% | 593,064 | 227.00K |
| 569 | ACXP | Acurx Pharmaceuticals, Inc. | 8.16M | -2.13% | 157,831 | - |
| 570 | TSBX | Turnstone Biologics Corp. | 8.11M | 1.10% | 236,685 | - |
| 571 | CDIO | Cardio Diagnostics Holdings, Inc. | 7.86M | -9.42% | 50,743 | 19.90K |
| 572 | APM | Aptorum Group Limited | 7.82M | -7.98% | 85,682 | - |
| 573 | CARM | Carisma Therapeutics, Inc. | 7.77M | 5.68% | 381,598 | 19.96M |
| 574 | SLXN | Silexion Therapeutics Corp | 7.75M | -2.99% | 302,018 | - |
| 575 | PMCB | PharmaCyte Biotech, Inc. | 7.66M | 2.29% | 9,682 | - |
| 576 | EVGN | Evogene Ltd. | 7.57M | 2.70% | 14,501 | 6.77M |
| 577 | PPBT | Purple Biotech Ltd | 7.19M | -3.33% | 49,526 | - |
| 578 | APLM | Apollomics, Inc. | 7.17M | - | 2,316 | 198.00K |
| 579 | CHRO | Channel Therapeutics Corporation | 7.09M | -0.46% | 29,595 | - |
| 580 | GTBP | GT Biopharma, Inc. | 6.99M | 0.42% | 18,964 | - |
| 581 | ADXN | Addex Therapeutics Ltd | 6.84M | -1.72% | 1,259 | 452.50K |
| 582 | GNPX | Genprex, Inc. | 6.59M | -2.08% | 735,289 | - |
| 583 | NLSP | NLS Pharmaceutics AG | 6.57M | 9.47% | 352,137 | - |
| 584 | KTTA | Pasithea Therapeutics Corp. | 6.55M | -3.51% | 182,530 | - |
| 585 | KLTO | Klotho Neurosciences, Inc. | 6.34M | 7.85% | 3,307,174 | - |
| 586 | RNAZ | TransCode Therapeutics, Inc. | 6.02M | -2.30% | 58,973 | - |
| 587 | IBO | Impact BioMedical Inc. | 6.02M | 2.47% | 412,418 | - |
| 588 | SNGX | Soligenix, Inc. | 6.01M | -3.16% | 27,975 | 2.34K |
| 589 | KZIA | Kazia Therapeutics Limited | 5.97M | -0.28% | 37,838 | 1.66M |
| 590 | CELZ | Creative Medical Technology Holdings, Inc. | 5.84M | -0.22% | 55,536 | 14.00K |
| 591 | INDP | Indaptus Therapeutics, Inc. | 5.56M | 2.09% | 230,320 | - |
| 592 | CNSP | CNS Pharmaceuticals, Inc. | 5.52M | -4.72% | 171,935 | - |
| 593 | MBIO | Mustang Bio, Inc. | 5.47M | -3.10% | 48,057 | - |
| 594 | ATNF | 180 Life Sciences Corp. | 5.45M | -1.78% | 18,454 | - |
| 595 | PSTV | Plus Therapeutics, Inc. | 5.42M | -9.55% | 4,673,134 | 5.21M |
| 596 | ADIL | Adial Pharmaceuticals, Inc. | 5.20M | -1.47% | 47,605 | - |
| 597 | QNRX | Quoin Pharmaceuticals, Ltd. | 5.15M | -2.72% | 6,056 | - |
| 598 | JAGX | Jaguar Health, Inc. | 4.93M | -2.50% | 55,648 | 11.55M |
| 599 | CMND | Clearmind Medicine Inc. | 4.83M | 3.96% | 956,125 | - |
| 600 | XBIO | Xenetic Biosciences, Inc. | 4.78M | 0.94% | 6,823 | 2.58M |
| 601 | SILO | Silo Pharma, Inc. | 4.61M | 12.08% | 18,372,697 | 72.10K |
| 602 | AZTR | Azitra, Inc. | 4.52M | -2.00% | 215,567 | 7.50K |
| 603 | DRMA | Dermata Therapeutics, Inc. | 4.49M | -0.56% | 189,942 | - |
| 604 | TTNP | Titan Pharmaceuticals, Inc. | 4.49M | 2.11% | 135,561 | - |
| 605 | MTNB | Matinas BioPharma Holdings, Inc. | 4.46M | 5.67% | 323,008 | - |
| 606 | TCRT | Alaunos Therapeutics, Inc. | 4.44M | 0.78% | 17,740 | 11.00K |
| 607 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.36M | 3.50% | 482,183 | 802.32K |
| 608 | GLTO | Galecto, Inc. | 4.23M | -3.03% | 52,512 | - |
| 609 | VRAX | Virax Biolabs Group Limited | 4.22M | 2.21% | 31,774 | 84.87K |
| 610 | THAR | Tharimmune, Inc. | 4.02M | -4.19% | 28,505 | - |
| 611 | TOVX | Theriva Biologics, Inc. | 3.86M | 2.84% | 433,515 | - |
| 612 | ENSC | Ensysce Biosciences, Inc. | 3.85M | -1.68% | 205,075 | 6.22M |
| 613 | SNPX | Synaptogenix, Inc. | 3.74M | 3.18% | 19,827 | - |
| 614 | LIXT | Lixte Biotechnology Holdings, Inc. | 3.70M | -0.72% | 11,433 | - |
| 615 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 3.66M | -1.28% | 15,554 | 1.00M |
| 616 | ARTL | Artelo Biosciences, Inc. | 3.61M | -0.05% | 61,919 | - |
| 617 | XRTX | XORTX Therapeutics Inc. | 3.61M | -2.66% | 26,578 | - |
| 618 | SPRC | SciSparc Ltd. | 3.57M | 4.95% | 102,240 | 1.31M |
| 619 | PCSA | Processa Pharmaceuticals, Inc. | 3.45M | -5.62% | 1,312,298 | - |
| 620 | NBY | NovaBay Pharmaceuticals, Inc. | 3.43M | -1.22% | 36,303 | 9.78M |
| 621 | GLMD | Galmed Pharmaceuticals Ltd. | 3.36M | -1.32% | 203,478 | - |
| 622 | GRI | GRI Bio, Inc. | 3.36M | -1.38% | 66,159 | - |
| 623 | BDRX | Biodexa Pharmaceuticals Plc | 3.32M | -0.86% | 135,827 | 104.90K |
| 624 | VIVS | VivoSim Labs, Inc. | 3.27M | 0.27% | 28,708 | 122.00K |
| 625 | PALI | Palisade Bio, Inc. | 3.26M | -5.18% | 116,229 | - |
| 626 | APVO | Aptevo Therapeutics Inc. | 3.24M | -3.63% | 58,326 | - |
| 627 | ENVB | Enveric Biosciences, Inc. | 3.11M | -2.33% | 169,970 | - |
| 628 | ONCO | Onconetix, Inc. | 3.08M | -5.44% | 2,626,714 | 2.52M |
| 629 | ZVSA | ZyVersa Therapeutics, Inc. | 3.08M | 3.96% | 2,717,640 | - |
| 630 | ADTX | Aditxt, Inc. | 3.05M | -7.69% | 296,303 | 55.32K |
| 631 | SCNI | Scinai Immunotherapeutics Ltd. | 3.03M | 28.97% | 20,506,293 | 658.00K |
| 632 | PBM | Psyence Biomedical Ltd. | 2.97M | -6.93% | 102,087 | - |
| 633 | ELAB | PMGC Holdings Inc. | 2.96M | -2.71% | 27,348 | 2.45M |
| 634 | QLGN | Qualigen Therapeutics, Inc. | 2.81M | -5.86% | 2,605 | - |
| 635 | ALZN | Alzamend Neuro, Inc. | 2.73M | -6.30% | 313,083 | - |
| 636 | OGEN | Oragenics, Inc. | 2.53M | -4.59% | 211,160 | - |
| 637 | ENTO | Entero Therapeutics, Inc. | 2.34M | 9.90% | 513,120 | - |
| 638 | CERO | CERo Therapeutics Holdings, Inc. | 2.30M | -4.89% | 524,235 | - |
| 639 | CDT | Conduit Pharmaceuticals Inc. | 2.15M | 0.75% | 393,547 | - |
| 640 | WINT | Windtree Therapeutics, Inc. | 2.15M | -11.76% | 448,585 | - |
| 641 | PTIX | Protagenic Therapeutics, Inc. | 2.05M | -8.29% | 224,329 | - |
| 642 | TNFA | TNF Pharmaceuticals, Inc. | 1.62M | -2.62% | 1,638,058 | - |
| 643 | SLRX | Salarius Pharmaceuticals, Inc. | 1.60M | -3.36% | 41,902 | - |
| 644 | REVB | Revelation Biosciences, Inc. | 1.34M | -7.85% | 1,264,955 | - |
| 645 | NCNA | NuCana plc | 239.25K | -14.32% | 74,691,556 | - |
| 646 | PLRZ | Polyrizon Ltd. | 23.04K | -4.89% | 370,283 | - |